Comparison of the effectiveness of Satureja khuzestanica and clotrimazole vaginal creams for the treatment of vulvovaginal candidiasis
- PMID: 33767795
- PMCID: PMC7982263
- DOI: 10.25122/jml-2020-0014
Comparison of the effectiveness of Satureja khuzestanica and clotrimazole vaginal creams for the treatment of vulvovaginal candidiasis
Erratum in
-
Correction to: Comparison of the effectiveness of Satureja khuzestanica and clotrimazole vaginal creams for the treatment of vulvovaginal candidiasis.J Med Life. 2021 Nov-Dec;14(6):871. doi: 10.25122/jml-2021-1007. J Med Life. 2021. PMID: 35126761 Free PMC article.
Abstract
Candidal vaginitis has a relatively high prevalence, and its resistance to treatment is on the rise. Considering the complications of chemical drugs, the use of herbal medicines has now been favored due to the lack of changes in the normal vaginal flora. The aim of this study was to compare the effectiveness of Satureja khuzestanica and clotrimazole vaginal creams for the treatment of candidal vulvovaginitis. A randomized clinical trial was conducted on 84 reproductive-aged women in the city of Ahvaz, Iran. Individuals were randomly divided into two treatment groups: 1% Satureja khuzestanica vaginal creams (n=42) and 1% clotrimazole vaginal cream (n=42) who used a one-full applicator daily for one week. About 4-7 days after the end of treatment, a clinical examination and laboratory re-tests were performed to determine the level of treatment. The data were analyzed using the Mann-Whitney U, t-test and Chi-square tests, with SPSS version 22. After the treatment, no significant difference was observed between the two groups in terms of vaginal discharge (p = 0.32), vaginal itching (p = 0.26), dysuria (p = 0.99) and dyspareunia (p = 0.60). Moreover, the results of culture (p = 0.62) and smear (p = 0.58) were not statistically significant in the two groups. Also, there was no significant difference between the two groups in terms of complete recovery after the treatment (p = 0.35). Satureja khuzestanica seems to have the same effect as clotrimazole in improving the symptoms of vaginal candidiasis, the negative results of culture and smear, as well as complete treatment.
Keywords: Satureja Khuzestanica; candidal vulvovaginitis; clotrimazole.
©2020 JOURNAL of MEDICINE and LIFE.
Figures
Similar articles
-
The Comparison of vaginal cream of mixing yogurt, honey and clotrimazole on symptoms of vaginal candidiasis.Glob J Health Sci. 2015 Apr 3;7(6):108-16. doi: 10.5539/gjhs.v7n6p108. Glob J Health Sci. 2015. PMID: 26153168 Free PMC article. Clinical Trial.
-
The efficacy of complementary treatment with marshmallow (Althaea officinalis L.) on vulvovaginal candidiasis: A randomized double-blinded controlled clinical trial.Explore (NY). 2023 Nov-Dec;19(6):813-819. doi: 10.1016/j.explore.2023.04.005. Epub 2023 Apr 17. Explore (NY). 2023. PMID: 37121836 Clinical Trial.
-
[A multicenter, randomized, open and positive parallel controlled clinical study of clotrimazole vaginal expansion suppository and vaginal tablet in the treatment of mild and moderate vulvovaginal candidiasis].Zhonghua Fu Chan Ke Za Zhi. 2020 Oct 25;55(10):697-702. doi: 10.3760/cma.j.cn112141-20200403-00293. Zhonghua Fu Chan Ke Za Zhi. 2020. PMID: 33120482 Clinical Trial. Chinese.
-
Interventions for prevention and treatment of vulvovaginal candidiasis in women with HIV infection.Cochrane Database Syst Rev. 2011 Aug 10;(8):CD008739. doi: 10.1002/14651858.CD008739.pub2. Cochrane Database Syst Rev. 2011. PMID: 21833970 Review.
-
Antimicrobial Activities of Satureja khuzestanica Jamzad; A Review.Infect Disord Drug Targets. 2021;21(2):161-167. doi: 10.2174/1871526520666200611102009. Infect Disord Drug Targets. 2021. PMID: 32525784 Review.
Cited by
-
From plants to particles: herbal solutions and nanotechnology combating resistant vulvovaginal candidiasis.Ther Deliv. 2024 Apr 23;15(5):371-92. doi: 10.4155/tde-2023-0133. Online ahead of print. Ther Deliv. 2024. PMID: 38651887 Review.
-
Correction to: Comparison of the effectiveness of Satureja khuzestanica and clotrimazole vaginal creams for the treatment of vulvovaginal candidiasis.J Med Life. 2021 Nov-Dec;14(6):871. doi: 10.25122/jml-2021-1007. J Med Life. 2021. PMID: 35126761 Free PMC article.
References
-
- Vicariotto F, Del Piano M, Mogna L, Mogna G. Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study. Journal of clinical gastroenterology. 2012;46:S73–S80. - PubMed
-
- Bornstein J, Zarfati D. A universal combination treatment for vaginitis. Obstetrical & Gynecological Survey. 2008;63(9):570–571.
-
- Buitrón RG, Romero RC, Cruz FT, Bonifaz A, Zarama FM. Study on Candida no-albicans species and its relation to recurrent vulvovaginal candidiasis. Ginecologia y obstetricia de Mexico. 2002;70:431–436. - PubMed
-
- Sobel JD. Vulvovaginal candidosis. The Lancet. 2007;369(9577):1961–1971. - PubMed
-
- Weissenbacher T, Witkin S, Ledger W, et al. Relationship between clinical diagnosis of recurrent vulvovaginal candidiasis and detection of Candida species by culture and polymerase chain reaction. Archives of gynecology and obstetrics. 2009;279(2):125–129. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources